Boyd joins the company from Longboard Pharmaceuticals, where he most recently served as Head of Business Development. Prior to this, he was Vice President of Investor Relations at Oxford Biomedica and ...

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Rigel Pharmaceuticals (RIGL) announced that it has entered into a settlement agreement with Annora Pharma Private Ltd., Hetero Labs Ltd., and Hetero USA resolving patent litigation related to ...

Vince Aurentz, former Executive Vice President and Chief Business Officer at Arena Pharmaceuticals and former member of the Board at Longboard Pharmaceuticals, Inc. Roberto Bellini, Managing ...

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on VRTX: Disclaimer & Disclosure Report an Issue Vertex Pharmaceuticals NewsMORE Related Stocks Indices Commodities ...

DUBLIN and DURHAM, N.C., March 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") and Chimerix (Nasdaq: CMRX) ("Chimerix ...

March 11, 2025 /PRNewswire/ -- Apnimed, Inc., a pharmaceutical company focused ... clinical and future commercial successes." At Longboard, Mr. Lind also led the initiation of a global Phase ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing Abelson Tyrosine Kinase inhibitor therapeutics for Cardiopulmonary disease. Inhibikase's ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers ...